ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$6.90
+0.09 (+1.32%)
As of Apr 1, 3:25 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +110.7% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $6.90
Current
$6.90
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
84.9%
Low target
Base Case
$14.54
+110.7%
Avg target
Bull Case
$24.66
+257.4%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$17.44
-60.4% from high
52-Week Low
$6.41
+7.7% from low
Target vs 52W High
$14.54
-16.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%